News from PredictImmune

Stay up to date with all the latest conference news, product launches and press releases from PredictImmune and its pioneering tools for the guidance of treatment options in immune-mediated diseases.

PredictImmune appoints new CEO

PredictImmune Appoints New CEO   Paul Kinnon appointed to drive the company’s next phase of development - commercialisation and expansion   Cambridge, UK, 02 July 2018: PredictImmune, a developer of pioneering prognostic products for guiding treatment...

read more

PredictImmune joins the Babraham Research Campus community

PredictImmune join the Babraham Research Campus community Developer of pioneering tools for guiding treatment options in immune-mediated inflammatory diseases choose Babraham Research Campus as permanent base within the Cambridge Cluster Babraham, 14th May 2018: The...

read more

Get in Touch

If you have an enquiry, contact PredictImmune using the following contact details. Alternatively, submit the enquiry form and one of our team will be in touch as soon as possible to see how we can meet your needs.

+44(0)1223 804 195

PredictImmune develops pioneering tools for guiding treatment options in immune mediated diseases such as Inflammatory Bowel Disease.

T +44 (0)1223 804 195
PredictImmune Ltd, Maia, Building 270
Babraham Research Campus
Cambridge CB22 3AT
United Kingdom